Diamond Biofund (TPE:6901) Other Financing: NT$0.00 Mil (TTM As of Dec. 2025)


TPE:6901 Diamond Biofund Inc TPE:6901
16 GF Score
Price NT$18.90
! 1 Warning Sign
View Full Analysis

What is Diamond Biofund Other Financing?

Diamond Biofund TPE:6901 +5.29% 16 Other Financing is NT$0.00 Mil as of Dec. 2025. GuruFocus rates TPE:6901 with a GF Score™ of 16/100. The stock has 1 warning sign investors should review.

Diamond Biofund's Other Financing for the three months ended in Dec. 2025 was NT$0.00 Mil.

Diamond Biofund's Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 was NT$0.00 Mil.

Diamond Biofund Other Financing Historical Data

* Premium members only.

The historical data trend for Diamond Biofund's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diamond Biofund Other Financing Chart

Diamond Biofund Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Diamond Biofund Quarterly Data
Dec19 Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.00 0.00 0.00 0.00 0.00
TPE:6901
16GF Score
Diamond Biofund Inc TPE:6901
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diamond Biofund Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of NT$0.00 Mil mean?
Diamond Biofund (TPE:6901) has a Other Financing of NT$0.00 Mil as of Dec. 2025. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Diamond Biofund and its competitors.
Is Diamond Biofund's Other Financing too high?
Diamond Biofund's current Other Financing is NT$0.00 Mil. Overall, Diamond Biofund has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Diamond Biofund's Other Financing compare to BLK and BX?
Diamond Biofund's Other Financing of NT$0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for an Asset Management company?
A good Other Financing depends on the Asset Management industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Diamond Biofund and its competitors. Diamond Biofund's current Other Financing is NT$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diamond Biofund stock overvalued right now?
Diamond Biofund (TPE:6901) has a current Other Financing of NT$0.00 Mil. The current Other Financing is NT$0.00 Mil. Diamond Biofund's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Diamond Biofund (TPE:6901), the current Other Financing is NT$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Diamond Biofund Business Description

Address Zhongxiao West Road, 34th Floor, No. 66, Section 1, Zhongzheng District, Taipei, TWN, 100
Diamond Biofund Inc is a sustainable biotech venture capital that focuses on the field of biotechnology and medical investment, targeting competitive investment targets, including new drug research and development, high-end medical equipment, medical service technology, medical access, agricultural biotechnology.
16GF Score

Get the complete analysis for TPE:6901

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$18.90
Price